作者：
Andrea,De Giglio [1]
;
Laura,Mezquita [2]
;
Edouard,Auclin [1]
;
Félix,Blanc-Durand [3]
;
Mariona,Riudavets [4]
;
Caroline,Caramella [5]
;
Gala,Martinez [1]
;
Jose Carlos,Benitez [1]
;
Patricia,Martín-Romano [6]
;
Lamiae,El-Amarti [1]
;
Lizza,Hendriks [1]
;
Roberto,Ferrara [7]
;
Charles,Naltet [1]
;
Pernelle,Lavaud [1]
;
Anas,Gazzah [8]
;
Julien,Adam [1]
;
David,Planchard [9]
;
Nathalie,Chaput [1]
;
Benjamin,Besse [1]
作者单位：
Cancer Medicine Department, Gustave Roussy, 94805 Villejuif, France.
[1]
Department of Specialized, Experimental and Diagnostic Medicine, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
[2]
Medical Oncology Department, Hospital Clinic, 08036 Barcelona, Spain.
[3]
Laboratory of Translational Genomics and Targeted therapies in Solid Tumors, IDIBAPS, 08036 Barcelona, Spain.
[4]
Medical and Thoracic Oncology Department, Georges Pompidou Hospital, 75015 Paris, France.
[5]
Radiology Department, Gustave Roussy, 94805 Villejuif, France.
[6]
Early Drug Development Department, Gustave Roussy, 94805 Villejuif, France.
[7]
Department of pulmonary diseases, GROW- School for Oncology and developmental biology, Maastricht UMC+, 6229 Maastricht, The Netherlands.
[8]
Thoracic Oncology Unit, Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
[9]
Department of Pathology, Gustave Roussy, 94805 Villejuif, France.
[10]
Laboratory of Immunomonitoring in Oncology and CNRS-UMS 3655 and INSERM-US23, Gustave Roussy, 94805 Villejuif, France.
[11]
Université Paris-Saclay, Faculté de Pharmacie, 92296 Chatenay-Malabry, France.
[12]
Université Paris-Saclay, Faculté de Médicine, 94276 Le Kremlin Bicêtre, France.
[13]
DOI
10.3390/cancers12102827
PMID
33007977
发布时间
2024-03-30
换一批
换一批
